Final stage of coagulation cascade

The "final stage of the coagulation cascade" refers to the terminal steps in blood clotting where **thrombin converts fibrinogen into insoluble fibrin monomers**, which then polymerize and are crosslinked by activated factor XIIIa to form a stable **fibrin mesh**. This process stabilizes the initial platelet plug and results in a mature blood clot that seals vascular injury[2][4][9]. The term "replication and augmentation" is not standard; it likely refers to amplification mechanisms within this phase but does not correspond to a specific molecular target or receptor. Instead, this is a physiological process involving multiple proteins rather than a single druggable entity. **Note:** This entry does not represent an individual molecule or receptor but rather describes a complex physiological event involving several factors such as thrombin, fibrinogen/fibrin, and factor XIIIa[2][4]. Therefore: > The provided name ("Replication and augmentation of final stage of coagulation cascade") is **not an accepted molecular target**; it describes an entire biological process. For structured data purposes, refer instead to specific components like "Thrombin," "Fibrinogen," or "Factor XIIIa" for actionable targets. If you need information on one specific protein involved in this phase (such as Thrombin), please specify for more precise details.

Other names

Replication and augmentation of final stage of coagulation cascadeFibrin clot formationFibrin polymerizationClot stabilization

Inhibition of thrombin activity; Inhibition of factor Xa activity; Prevention of fibrinogen conversion to fibrin.